Theravance Biopharma, Inc. (TBPH)
19.39
-0.11
(-0.56%)
USD |
NASDAQ |
Feb 10, 14:18
Theravance Biopharma Total Liabilities (Quarterly) : 182.78M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 191.70M |
| Nektar Therapeutics | 216.26M |
| Innoviva, Inc. | 419.16M |
| Oramed Pharmaceuticals, Inc. | 18.16M |
| Skye Bioscience, Inc. | 8.488M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 415.46M |
| Shareholders Equity (Quarterly) | 232.68M |
| Debt to Equity Ratio | 0.1917 |
| Current Ratio | 9.482 |
| Net Debt Paydown Yield | 0.06% |